Minneapolis St. Paul Mental Health Blog

Past-year use of marijuana and hallucinogens, as well as binge drinking rates, for adults between the ages of 35 and 50 reached all-time highs in 2022, according to a report released on Thursday by the National Institute on Drug Abuse (NIDA).

Mental Health | Past-year use of marijuana and hallucinogens, as well as binge drinking rates, for adults between the ages of 35 and 50 reached all-time highs in 2022,...

...according to a report released on Thursday by the National Institute on Drug Abuse (NIDA).

Young men with cannabis use disorder are at an increased risk of developing schizophrenia...

...according to a study released this week by the National Institute on Drug Abuse (NIDA) at the National Institutes of Health (NIH).

Marijuana smokers were found to have higher rates of emphysema and airway diseases compared to cigarette smokers in a study conducted by researchers from the University of Ottawa and The Ottawa Hospital.

Delta-9-Tetrahydrocannabinol (THC), the main psychoactive component of cannabis, remains detectable in breast milk even after weeks of abstinence, new data show.

The estimated half-life of THC in breast milk is 17 days, according to the study results, with a projected time to elimination of more than 6 weeks.

The clinical importance of the remaining THC is up for debate, according to some experts.

Op-Ed: Are Marijuana Use and Suicide Linked?

— A review of the data show there's cause for alarm

Correlation does not mean causation, but that is why we do research -- to follow correlations in an effort to determine causation. Data linking marijuana use to people with suicidal ideation, attempts, and completed suicides are steadily increasing.

The effects of Marijuana Dependency, costs and risks of your health

Cannabis Dependency May Affect Outcomes in Asthma Exacerbation Hospitalizations

With more women using marijuana early in pregnancy to combat nausea and other conditions, ...

...researchers are raising concern about potential harms of use to a developing fetus.

Mental Health | Designer drugs, especially synthetic opioids and cannabinoids, are presenting increasing challenges to psychiatrists treating patients with overdoses or psychiatric adverse effects.

Mental Health | Too many questions about cannabis and cannabinoids remain unanswered for mental health clinicians to use them in clinical practice, a panel of researchers told an overflow crowd at the American Psychiatric Association Annual Meeting.

The presenters reviewed the medical literature on cannabis and cannabinoids relating to schizophrenia, anxiety disorders including social anxiety disorder, post-traumatic stress disorder, and other conditions.